Effect of antihypertensive therapy in preeclampsia on levels of serum ilnterleukin-4

Gynecologic and Obstetric Investigation

Volumn 42, Issue 4, 1996, Pages 230-236

  Omu, Alexander E ^a   Makhseed, Ma’asoumah ^a   Al Qattan, Fawzia ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antihypertensive therapy; Interleukin 4; Preeclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; INTERLEUKIN 4;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABOR; PREECLAMPSIA; PRIORITY JOURNAL; PUERPERIUM;

ADULT; ANTIHYPERTENSIVE AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDRALAZINE; INFUSIONS, INTRAVENOUS; INTERLEUKIN-4; LABETALOL; METHYLDOPA; PRE-ECLAMPSIA; PREGNANCY;

EID: 10544247323     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291969     Document Type: Article

References (44)

1. Redman CWE. Walker I: Preeclampsia. The Facts: The Hidden Threat to Pregnancy. Oxford. Oxford University Press. 1992.
2. Sibai BM. Taslimi M. Abdella TM. Brooks TF. Spinnato JA. Anderson GD: Maternal and perinatal outcome of conservative management of severe preeclampsia in mid trimester. Am J Obstet Gynecol 1985;87:32-37.
3. Diejomaoh FME. Omcne JA. Omu AE: Pre-eclampsia and eclampsia at the University of Benin Teaching Hospital: A review of 226 cases. Trop J Obstet Gynecol 1981; 1:91-96.
4. Redman CWG. Beilin I.J. Bonnar J. Ounstcd MK: Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976;vol ii:753-756.
5. Australian Society for Study of Hypertension in Pregnancy: Consensus statement: The management of hypertension in pregnancy. New Era Printing Ptv Ltd. 570 5288.
6. Rubin PC. Clark DM, Simmer DJ: Placebo controlled trial of atenolol in treatment of pregnancy associated hypertension. Lancet 1983;vol i: 431-434.
7. CLASP Collaborative Group: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9,364 pregnant women. Lancet 1994:343:619-629.
8. Sibai BM. Ramadan MK: Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstct Gynecol 1993:169:1000-1006.
9. Repke JT: Prevention of pre-eclampsia. Clin Perinatol 1991:18:779-804.
10. Roberts JM. Taylor RM. Musci JJ, Rodgers GM: Serum from preeclamptic women contains a factor which damages human endothelial cells. Clin Exp Hypcrtcns 1989:8:119-123.
11. Mitchell MD., Trautman MS., Dudley DJ:Cyto-kines networking in the placenta. Review article. Placenta 1993;14:249-275.
12. Opsjon S. Wathen NC. Tingulstad S, Wicds-wang G, Sundan A. Waage A. Anstgulen R: Tumour necrosis factor, interleukin-1 and in-tcrleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993:169:397-404.
13. Vince GS. Starkey PM. Austgulcn R. Kwiat-kowski D. Redman CWG: Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with pre-eclampsia. Br J Obstel Gynaecol 1995;102:20-25.
14. Kupfermine MJ, Peaceman AM. Wigton TR. Rehnberg KA, Socol ML: Tumor necrosis factor is elevated in plasma and amniotic fluid of patients with severe pre-eclampsia. Am J Obstet Gynecol 1994;170:1752-1759.
15. Meekins JW. McLaughlin PJ, West DC, McFa-dven IR. Johnson PM: Endothelial cell activation by tumor necrosis factor-alpha (TNF-a) and development of pre eclampsia. Clin Exp Immunol 1994:98:110-114.
16. Yokota T. Otsuka T, Mosmann T, Banchcreau J. De Fame T. Blanchard D, et al: Isolation and characterisation of a human interleukin CDNA clone homologous to mouse B-cell stimulating factor-1 that expresses B cell and T cell stimulating activities. Proc Natl Acad Sei USA 1986; 83:5894-5898.
17. Spits H, Yssel H. Takebc Y, Arai N, Yokota T, Lee F, Arai K. Banchereau J, De Vries JE: Recombinant interleukin-4 promotes the growth of human T cells. J Immunol 1987:139: 1142-1147.
18. Pene J. Rousset F, Briere F, Chretien I, Paliard X. Banchcreau J, Spits H. De Vries JE: IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J Immunol 1988;141:1218-1224.
19. Joncs CA, Williams KA. Finlay-Jones JJ. Hart PH: Interleukin-4 production by human amnion epithelium cells and regulation of its activity by glycosantinoglycon. Biol Reprod 1995;52:839-847.
20. Littman BH. Dastvan PL, Sanders KM: Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (OSF-I) and IFN gamma. J Immunol 1989:142:520-525.
21. Ohara J. Paul WE: Receptors for B-cell stimulatory factor-1 expressed on cells of hematopoietic lineage. Nature 1987;325:537-540.
22. Adamson S. Edwin SS. La Marche S. Mitchell MD: Action of IL-4 on prostaglandin biosynthesis at the choriodccidual interface. Am J Obstct Gynecol 1993:169:1442-1447.
23. Bry K, Lappalainen U: Interleukin-4 and transforming growth factor B, modulate the production of interleukin receptor antagonists and of prostaglandin E2 by decidual cells. Am J Obstct Gynecol 1994:170:1194-1198.
24. Hayakawa M. Maki M: Coagulation-fibrinolyt-ic and kinin-forming system in toxaemia of pregnancy. Gynecol Obstet Invest 1988;26: 181-190.
25. Delassus S. Coutinho GC. Saucier C, Darche S. Kourilsky P: Differential cytokine expression in maternal blood and placenta during murine gestation. J Immunol 1994:152:2411-2420.
26. Omu AE. Makhseed M. Al-Qattan F: The comparative values of interleukin (IL-4) in sera of women with pre eclampsia and cord sera. Nutrition 1995;11:688-691.
27. Hill JA, Polgar K. Anderson DJ: T-Helpcr I-type immunity trophoblast in women with recurrent abortion. JAMA 1995;273:1933-1936.
28. Chaouat G, Menu E. Clark D. Dy M, Minkowski M, Wegmann TG: Control of fetal survival in CBAX DBA/2 mice by lymphokinc therapy. J Reprod Fertil 1990;89:447-458.
29. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship. Is a successful pregnancy a Th 2 phenomenon? Immunol Today 1994:14:353-356.
30. Lin H, Mosmann TR, Guilbert L, Tuntipopi-pat S, Wegmann TG: Synthesis of T helper 2-type cytokine at the maternal-fetal interface. J Immunol 1993;1511:4562-4573.
31. La Marches, Mitchell MD: Actions of interleukin-4 on prostaglandin production by human amnion. Clin Res 1992;40:25-29.
32. Roberts JM, Taylor RM. Goldfein A: Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol 1991:15:86-93.
33. Roberts JM, Redman CWG: Precclampsia: More than pregnancy induced hypertension. Lancet 1993;341:1447-1451.
34. Rodgers GM. Taylor RN. Roberts JM: Pre-eclampsia is associated with a serum factor that is cytotoxic to human endothelial cells. Am J Obstct Gynecol 1988;159:908-914.
35. Romero R, Duran S. Dinarello CA, Oyarzunt E. Hcbbins JC. Mitchell MD: Interleukin stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989:37:13-22.
36. Redman CW, Sargent IL: Immunological disorder of human pregnancy. Oxf Rev Reprod Biol 1986;8:223-265.
37. Steck T. Würfel W: The role of immunological factors in the etiology of pregnancy induced hypertension. Zcntralbl Gynäkol 1995:1 17:3-10.
38. Hart PH. Vitty GF. Burgess DR. Whitty GA, Piccoli DS. Hamilton JA: Suppression of human monocytes tumor necrosis factor a. Interleukin-1 and prostaglandin E2. Proc Natl Acad Sei USA 1989;86:3803-3807.
39. Bendlzen K. Svenson M. Jonsson V, Hippe V: Autoantibodics to cytokines: Friend or foes. ImmunolToday 1990:11:167-169.
40. Colbcm GT, Chiang MH, Main EK: Expression of non-classic histocompatibility antigen by pre-eclamptic placenta. Am J Obstct Gynecol 1994;170:1244-1250.
41. Labaarrare CA, Faulk WP: Intercellular adhesion molecule-l(ICAM-l) and HLA-DR antigens arc expressed on cndovascular cytotro-phob'asts in abnormal pregnancies. Am J Reprod Immunol 1995;33:47-53.
42. Bolis PF. Martinetti Bianchi M, La Fianza A, Franchi M, Cuccia Belvedere M: Immunogcn-etic aspect of prceclampsia. Biol Res Pregnancy Perinatol 1987;8:42-45.
43. Hu-Li J. Shevach EM. Ohara J, Mosmann T, Paul WE: B cell stimulatory factor 1 (interleukin-40) is a potent stimulant for normal resting T lymphocytes. J Exp Med 1987;165:157-172.
44. Kilpatrick DC. Liston WA, Gibson F. Livingstone J: Association between susceptibility to precclampsia within families and HLADR. Lancet 1990:335:660-661.